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Congenital nephrogenic diabetes insipidus (NDI) is a disease characterized by failure of the kidney to concentrate urine
in response to vasopressin. Human kindreds with nephrogenic diabetes insipidus have been found to harbor mutations
in the vasopressin receptor 2 (Avpr2) gene or the vasopressin-sensitive water channel aquaporin-2 (Aqp2) gene.
Development of a treatment is rendered difficult due to the lack of a viable animal model. Through forward genetic
screening of ethylnitrosourea-mutagenized mice, we report the identification and characterization of a mouse model
of NDI, with an F204V mutation in the Aqp2 gene. Unlike previously attempted murine models of NDI, our mice survive
to adulthood and more exactly recapitulate the human disorder. Previous in vitro experiments using renal cell lines
suggest recessive Aqp2 mutations result in improper trafficking of the mutant water pore. Using these animals, we
have directly proven this hypothesis of improper AQP2 translocation as the molecular defect in nephrogenic diabetes
insipidus in the intact organism. Additionally, using a renal cell line we show that the mutated protein, AQP2-F204V, is
retained in the endoplasmic reticulum and that this abnormal localization can be rescued by wild-type protein. This
novel mouse model allows for further mechanistic studies as well as testing of pharmacological and gene therapies for
NDI.
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Introduction
Nephrogenic diabetes insipidus (NDI) is a disease charac-
terized by excessive urination and thirst, despite normal
production of the antidiuretic hormone arginine vasopressin
(AVP) [1]. The inherited forms are either X-linked as a
consequence of mutation of the Avpr2 gene [2], or autosomal
due to mutation of the Aqp2 gene [3]. Aquaporin-2 (AQP2) is
a pore-forming protein belonging to a family of water
channels [4], and it is expressed in collecting-duct principal
cells in the kidney [5]. Generally these proteins permit the
passage of water through the plasma membrane (PM) of cells,
several of which carry out this role speciﬁcally in the process
of water reabsorption from urine in the kidney. It has been
established that aquaporins, although functional as a mono-
mer, tetramerize before their insertion into the plasma
membrane [4,6]. Furthermore these proteins can also be
differentially targeted to distinct regions of the PM; for
example, AQP2 is routed to the apical membrane of cells
surrounding the collecting duct, whereas other aquaporins
(AQP3 or 4) are inserted into the basolateral face. Unlike all
other family members, AQP2 is not constitutively inserted
into the plasma membrane. Under basal conditions, the
protein resides in subapical intracellular vesicles; however,
under conditions requiring water retention AQP2 trans-
locates to the apical membrane, permitting water reabsorp-
tion [7,8]. For this process to occur, AVP binds its receptor,
AVPR2, on the basolateral face of the collecting duct cells,
leading to a rise in intracellular cAMP, ultimately resulting in
phosphorylation of AQP2 at serine 256 by cAMP-dependent
protein kinase [9] and its redistribution to the plasma
membrane.
The importance of AQP2 redistribution has been high-
lighted by functional characterization of Aqp2 mutations
resulting in severe NDI in humans [3,10]. Recessive Aqp2
mutations are generally thought to produce an abnormally
localized and, in most instances, misfolded water pore that
responds abnormally to an increase in cAMP [6,11]. Fur-
thermore, dominant mutations have been described and
found to misroute both the mutant and the wild-type protein
to the basolateral membrane [6,12].
Several mouse models of diabetes insipidus have been
generated [13–17]. In an attempt to recapitulate human NDI,
mice have been generated with mutations in Aqp2 and Avpr2
[15,18]. Yang and colleagues created a mouse with a T126M
knock-in mutation in the Aqp2 gene. Unexpectedly, homo-
zygous mutant mice died within 6 d after birth. Interestingly,
AVPR2-deﬁcient male pups also die within the ﬁrst week after
birth. Together these models suggest that the mouse may be a
highly sensitive organism with regard to water homeostasis,
and is unable to survive with polyuria.
In a forward genetic screen, a mouse with an Aqp2 mutation
was identiﬁed. The purpose of this study was to characterize
this murine model of recessive nephrogenic DI. We now
report a novel F204V mutation in the Aqp2 gene. This allele of
Aqp2 was found to cause the ﬁrst mouse model of NDI to
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concluded that mutant AQP2 adopts a different subcellular
localization in renal collecting-duct cells, and was resistant to
translocation induced by desmopressin, an agonist of AVP. In
vitro studies using the Madin-Darby canine kidney (MDCK)
cell line demonstrated an endoplasmic reticulum pattern for
the mutant protein, and apparent resistance to translocation.
These data conclusively prove that autosomal recessive NDI is
a consequence of improper AQP2 routing in the intact
mammal.
Results
In a forward genetic screen that used ethylnitrosourea
(ENU) to induce mutations in a founder animal whose
offspring were then screened for abnormal whole body
metabolism [19,20], we found a family of mice that urinated
and drank excessively. Serum and urine analysis showed that
plasma glucose levels were normal and there was no glucose
in the urine (unpublished data). Hence, this was an example
of diabetes insipidus.
The disorder in these mice segregated in a monogenic,
autosomal recessive manner, making Aqp2 a candidate gene.
Sequencing of Aqp2 coding region of affected mice identiﬁed
a thymine to guanine (T to G) transversion (Figure 1A), which
is predicted to lead to a valine for phenylalanine substitution
at amino acid 204 of the protein (F204V).
AQP2 is a six-transmembrane water channel, and F204 lies
near the extracellular face of the sixth membrane spanning
domain, a region rich in hydrophobic amino acids. This and
the other membrane-spanning domains are conserved among
vertebrate species. The phenylalanine at position 204 is
particularly well conserved (Figure 1B), not only among
vertebrate AQP2 proteins, but also among others members of
this family.
Aqp2
F204V/F204V mice have dramatically increased urine
production, in some cases producing an amount of urine in
24 h that exceeds their body weight, compared to their
heterozygous or wild-type littermates. Such loss of water
would rapidly lead to dehydration were it not compensated
by increased water intake. Indeed, mutant mice also
dramatically increase their water intake (Figure 1C) com-
pared to their heterozygous or wild-type littermates. This
phenotype—increased urinary output and water intake—
showed complete concordance with homozygosity of the
F204V mutation in the 58 animals tested.
Diabetes insipidus can be deﬁned as an inability to
concentrate urine where appropriate. Compared to wild-
type or heterozygous littermates, Aqp2
F204V/F204V mice pro-
duce very dilute urine (Figure 1D). Basal urine concentration
in mutant mice is about 161 mOsm, compared to about 1,293
mOsm in wild-type mice (p , 0.001). Normally, urine
concentration is under the control of the hypothalamus,
which, in response to hypovolemia or hypernatremia [21],
secretes AVP. The synthetic AVP analog, 1-deamino-8-D-
arginine vasopressin (dDAVP; also called desmopressin), is a
potent agonist of AVPR2. When administered to wild-type
mice, dDAVP leads to a dramatic increase in urine concen-
Figure 1. Analysis of Aqp2 Sequence and Phenotype in Mutant Mice
(A) Chromatographic traces of Aqp2 F204V mutation. The box shows the
mutated codon, TTC (Phe) to GTC (Val) at position 204.
WT, wild type; Mut, mutant.
(B) Amino acid conservation of mouse AQP2 (residues 194–214). The
boxed residue indicates phenylalanine at position 204.
hAQP2, human AQP2; mAQP1, mouse AQP1; mAQP2, mouse AQP2;
rAQP2, rat AQP2; xAQP2, Xenopus AQP2.
(C) Urine production (ml) and water consumption (ml) of 58 F2 mice over
a 24-h period (both sexes, aged 10–22 wk). Mutant mice (black squares)
exhibit overt polyuria and polydipsia compared to littermate wild-type
(white triangles) and heterozygous (grey circles) mice.
(D) Urine osmolality and concentrating ability in Aqp2 mutant and their
littermates (10–22 wk, both sexes), before (white bars) and after (black
bars) dDAVP treatment. Wild type (WT; n ¼ 12); heterozygote (Het; n ¼
20); mutant (Mut; n¼9). Data represent averages 6 standard error of the
mean, **p , 0.01; ***p , 0.001.
DOI: 10.1371/journal.pgen.0010020.g001
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Synopsis
Nephrogenic diabetes insipidus (NDI) is a disease marked by
excessive urination and thirst. Normally, the hypothalamus senses
situations where water is limited and signals to the kidney to
increase water reabsorption from urine. The signaling molecule
secreted by the hypothalamus is arginine vasopressin (AVP), which
binds to a specific protein on the surface of kidney cells, AVP
receptor (AVPR2). AVP binding to its receptor on kidney cells begins
a series of biochemical events that ultimately results in the insertion
of a protein, aquaporin 2 (AQP2), into the outer surface of the kidney
cell. As its name suggests, AQP2 facilitates the reuptake of water
from the urinary space into the cell, thus concentrating the urine
and conserving water. Congenital NDI is caused by mutations in
either the water channel, AQP2, or in the receptor, AVPR2. While
these mutations have been studied extensively in the lab, work in
live animals has been very limited. This report describes the first
viable mouse model of NDI. Previous models have been attempted
by targeted mutation, i.e., genes known to be involved in the
disease have been altered in the mouse, a so-called reverse genetic
approach. Reverse genetic approaches have so far failed to produce
a viable mouse model of NDI. Here the authors take a forward
genetic approach in which genes are mutated at random and
animals are screened for disease-like properties. As well as proving
hypotheses that come from lab studies, this model opens the door
to the testing of gene therapy or other therapies for treatment of
NDI.tration, from 1,293 to 5,885 mOsm (4.6-fold; Figure 1D). With
similar treatment, mutant mice concentrate their urine to a
lesser but still signiﬁcant extent, from 161 to 470 mOsm (2.9-
fold), indicating that these animals are not only unable to
concentrate their urine properly but are also defective in
their response to dDAVP. The smaller response to dDAVP
indicates some residual activity of the mutant AQP2 channel,
which must be sufﬁcient to allow survival of the individual, in
contrast to the T126M knock-in mouse [18].
Multiple heterozygous matings yielded 101 animals, which
appeared at a ratio of 26:49:26, near the expected Mendelian
wild type, heterozygote, and mutant frequencies, respectively,
indicating that there is no reduced viability associated with
this mutation. Other than the increased urine production
and water intake, there was no overt phenotype in mutant
mice, save distended kidneys, which appeared variably in
adult animals (Figure 2A). Although not speciﬁcally mea-
sured, mutant mice seem to have a normal lifespan. The one
animal that was followed lived to 18 mo, typical for animals in
our colony.
Aqp2
F204V/F204V mice suffer from severe hydronephrosis
(Figure 2A and 2B), presumably as a consequence of an
inability to cope with the extreme polyuria. We found
distended kidneys in all Aqp2
F204V/F204V mice; however, the
degree of inﬂation was variable in affected mice and
worsened with age. Severe hydronephrosis has previously
been observed in double Aqp1/Aqp3 knock-out mice [17], and
appears at 6 wk. Even at 4 wk, Aqp2
F204V/F204V mice had
hydronephrosis. Histologic sections from Aqp2
F204V/F204V mice
demonstrated marked dilatation of the renal pelvis yet
normal morphology of the ureter (Figure 2C and 2D). In
particular, the muscularis propria was neither hypertrophied
nor thinned. There was the normal festooned appearance of
the urothelium, and this transitional epithelium was of
normal thickness. There was thinning of the kidney as
measured from renal capsule to renal pelvis. However, the
morphologic features of the glomeruli and proximal/distal
tubules were unremarkable (Figure 2D).
As shown previously [18,22], immunoblotting revealed three
different forms of AQP2, due to different degrees and forms
of glycosylation (Figure 3A). Previous reports have demon-
strated that nonglycosylated protein appears as a 29 kDa band,
while complex glycosylated protein runs as a smear between
35 and 45 kDa. A short-lived intermediate form of 31 kDa
representing core, high-mannose glycosylation of AQP2 is
apparent from pulse-chase labeling experiments [22]. Com-
pared to that from the kidneys of wild-type animals, AQP2
from mutant animals was reduced in both the high molecular
weight, diffuse form and the lowest molecular weight form,
but enriched in the intermediate molecular weight form
(Figure 3A). Heterozygous animals showed intermediate
amounts of all three forms. The nature of these glycosylated
forms was revealed by digestion with endoglycosidase H,
which speciﬁcally cleaves mannose-rich carbohydrate from
the protein backbone. Treatment of endogenous AQP2 from
kidneys of wild-type, heterozygous, and mutant animals
speciﬁcally affected the intermediate molecular weight form
(Figure 3B). The presence of some mature glycosylated
proteins (35–45 kDa) in Aqp2
F204V/F204V mice presumably
permits their survival compared to Aqp2
T126M/T126M mice,
and is consistent with a diminished response to dDAVP.
In humans, recessive alleles of Aqp2 are postulated to cause
NDI because they do not properly translocate to the apical
cell surface in response to AVP. This postulate comes solely
from in vitro studies in which mutant Aqp2 cDNAs corre-
sponding to human disease mutations are transfected into
kidney cell lines. In general, such recessive alleles, when
visualized immunocytochemically, fail to localize to AVP-
responsive vesicles. Rather, they get trapped in the endoplas-
mic reticulum (ER). Our mouse model of NDI affords the ﬁrst
opportunity to test this hypothesis in a mature animal. As
shown in Figure 4A (top row of photomicrographs), AQP2
(stained red) normally localized to the subapical region of
collecting duct cells in kidneys of wild-type mice. Upon
stimulation with dDAVP, AQP2 translocated to or near the
Figure 2. Anatomy and Histology of Mouse Kidneys
(A) Gross anatomy of an affected mouse (8-mo-old male). This shows the
enlargement and cystic dilatation of the renal pelvis. There is thinning of
the overlying renal parenchyma imparting a translucent appearance to
portions of the kidney and collecting system. The bladder is also dilated.
(B) Left kidney from mutant mouse (right) shown in (A) compared to a
kidney from an age-sex matched unaffected littermate (left).
(C) Hematoxylin and eosin stained section of ureter from a mutant
mouse, showing normal histology despite bloating of the kidney.
(D) Hematoxylin and eosin stained histologic section of a kidney from a
4-wk-old female mutant mouse. The mutant kidney shows marked
dilatation of the renal pelvis with blunting of the papilla. There is
preservation of the cortex and medulla.
DOI: 10.1371/journal.pgen.0010020.g002
Figure 3. Immunoblot Analyses of AQP2 from Mouse Kidneys
(A) Western blot analyses of total kidney membranes from littermate
mice. An intermediate form of AQP2 at 31 kDa was identified in kidney
membranes from a mutant mouse (Mut) and partially in a heterozygous
mouse (Het).
(B) Total kidney membranes were subjected to endoglycosidase H
treatment (Endo H) prior to Western blotting. High-mannose (h.m.)
glycosylated proteins that have not exited the ER are sensitive to
endoglycosidase H digestion.
DOI: 10.1371/journal.pgen.0010020.g003
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Aquaporin-2 Mutant Micecell surface (Figure 4A, second row). In kidneys taken from
mutant animals, however, AQP2 was distributed randomly
throughout the cell in the basal state (Figure 4A, third row),
while AQP3 (green) appropriately localized to the basolateral
surface [23]. Furthermore, upon dDAVP stimulation, AQP2-
F204V failed to translocate to the cell surface (Figure 4A,
bottom row). To conﬁrm these ﬁndings, the staining was
repeated in kidneys taken from two further mice for each
class, wild-type or mutant, with or without dDAVP treatment,
with identical results.
To investigate the mechanism of defective translocation of
AQP2-F204V, we turned to transfection of MDCK cells.
Stable cell lines expressing mouse wild-type AQP2 and AQP2-
F204V were established. Immunoblots of protein extracts
from stable cell lines showed that MDCK cells recapitulate the
glycosylation defect seen in mutant mice (unpublished data).
The wild-type protein was again present in three different
forms. Cells expressing AQP2-F204V lacked the 35–45 kDa
form and were enriched in the core-glycosylated 31 kDa form.
In transfected, unstimulated MDCK cells, wild-type AQP2
(stained green) appeared in a punctate pattern distributed
throughout the subapical region (Figure 4B, left column
photomicrographs), consistent with vesicular compartmen-
talization. AQP2-F204V, on the other hand, appeared in a
punctate but perinuclear pattern (Figure 4B, third column).
Upon stimulation with forskolin, a cAMP-dependent protein
kinase activator, wild-type AQP2 translocated to the apical
surface of polarized MDCK cells (Figure 4B, second column).
Along the z-axis, the perinuclear distribution of AQP2-F204V
was clearly seen, and this distribution is not altered by
forskolin (Figure 4B, bottom row, two right columns). The
perinuclear distribution of AQP2-F204V is consistent with an
ER compartmentalization. To test the idea that AQP2-F204V
localizes to the ER, we co-stained cells transfected with
Aqp2
F204V (cDNA) for AQP2 and an ER marker, calnexin
(Figure 4C). Colocalization of calnexin with AQP2 was
investigated directly, and it was found that 80% of all
AQP2-F204V protein colocalized with calnexin. The remain-
ing 20% appeared at the periphery of the ER, representing
AQP2-F204V that had potentially progressed beyond the ER.
This ‘‘ER escape’’ was consistent with the small proportion of
mature, complex glycosylated, AQP2-F204V in mutant
kidneys (see Figure 3A).
Animals heterozygous for the Aqp2
F204V mutation were not
affected in their urine production or urine osmolality (see
Figure 1C and 1D). It has also been shown that a recessive
NDI allele, AQP2-R187C, does not interact with wild-type
protein in oocytes [24], nor does it homo-oligomerize in
MDCK cells [22]. Therefore, kidneys from heterozygous
animals were examined for evidence of two populations of
AQP2 protein. Surprisingly, immunohistochemical staining
of kidney collecting ducts from Aqp2
F204V/þ mice revealed a
Figure 4. AQP2 Subcellular Localization and Translocation in Mouse Kidney Collecting Ducts and MDCK Cell Lines
(A) Immunohistochemistry on collecting ducts in kidney sections from an AQP2-F204V mutant (Mut) mouse and an age-sex matched wild-type (WT)
littermate. Mice were injected intraperitoneally with PBS (NT) or dDAVP before sacrificing and fixation of the kidneys. Kidneys sections were
immunostained for AQP2 (red) and the basolateral marker AQP3 (green). The images were merged and an area of the cytoplasm was magnified (zoom).
Note that mutant AQP2 is not properly localized to the subapical compartment, nor does it respond to dDAVP.
(B) MDCK cell lines, stably transfected with constructs encoding mouse WT or AQP2-F204V, were treated with and without 150 lM forskolin for 90 min,
after which cells were fixed, permeabilized, and subjected to immunocytochemistry. AQP2 is shown in green, and the basolateral marker Na
þ/K
þ-ATPase
is shown in red, alongside the nuclear stain DAPI. The z-profile images were reconstructed from multiple z-sections, along the dotted line. Mutant AQP2
fails to localize to the cell surface upon forskolin stimulation. Rather, the perinuclear staining is consistent with an ER localization of mutant AQP2.
(C) The MDCK cell line expressing AQP2-F204V was grown on fibronectin-coated coverslips until tight junctions formed, at which point the cells were
treated with 150 lM forskolin for 90 min. Cells were fixed, permeabilized, and sequentially immunoblotted for AQP2 (green) and calnexin (red), an ER
marker. The merged image shows that AQP2-F204V colocalizes with the endoplasmic reticulum marker. Scale bar refers to 10 lm.
DOI: 10.1371/journal.pgen.0010020.g004
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Aquaporin-2 Mutant Micepattern remarkably similar to wild type (Figure 5A). AQP2
translocated completely to the apical cell surface upon
dDAVP stimulation. This wild-type staining pattern may
simply reﬂect the fact that decreasing the amount of mutant
protein by half makes it undetectable by immunocytochem-
istry. Alternatively, the presence of wild-type protein may
alter the localization of the mutant protein. Indeed, Hendriks
et al. proposed a ‘‘piggy-back’’ mechanism to explain the
transport of nonglycosylated subunits of AQP2 to the cell
surface by glycosylated subunits [22]. It has also been shown
that wild-type AQP2 protein can rescue a translocation-
defective mutant protein, AQP2-P262L, when the two are
coexpressed in MDCK cells [25].
In the collecting ducts from Aqp2
F204V/þ mice, the wild type
may rescue the mutant protein as suggested by the subcellular
distribution of AQP2 protein. To test this idea, we ﬁrst
looked for an interaction between mutant and wild-type
proteins in transfected MDCK cells (Figure 5B). MDCK cells
stably expressing wild-type AQP2 were transiently trans-
fected with GFP expression constructs encoding GFP-tagged
wild-type AQP2, AQP2-F204V, or GFP alone. Antibodies
against GFP coimmunoprecipitated wild-type AQP2 when
AQP2-GFP or AQP2-F204V-GFP was transiently transfected,
but not when GFP by itself was transiently transfected into
MDCK cells stably expressing wild-type AQP2 (Figure 5B,
upper blots). Western blot of total membranes showed that
wild-type AQP2 is equivalently expressed in all three cases
(Figure 5B, lower blots).
If wild-type and mutant proteins are indeed interacting in
the cell, is this interaction sufﬁcient to rescue the localization
of mutant protein? To answer this question, we used MDCK
cells stably transfected with wild-type AQP2 expressing vector
or with empty vector. On top of these, we transiently
transfected AQP2-GFP or AQP2-F204V-GFP expression
constructs. AQP2-GFP localized to the apical surface upon
forskolin stimulation whether it was transiently transfected
into vector-only cells (Figure 5C, upper left images) or into
wild-type AQP2 cells (Figure 5C, upper right). AQP2-F204V-
GFP, when expressed by transient transfection into vector
only cells, showed a diffuse cytoplasmic distribution pattern
(Figure 5C, lower left). When expressed in wild-type AQP2
cells, however, AQP2-F204V-GFP localized to the apical
surface to varying degrees (Figure 5C, lower right images [i–
iii]). The lower right images of Figure 5C shows three cells
from a single transfection. The ﬁrst is a nontransfected cell
that shows the localization of the stably expressing wild-type
AQP2, which is apical upon forskolin stimulation. The next
two show expression of both the stable wild-type AQP2 and
the transient AQP2-F204V-GFP. In cell (ii), localization of
wild-type AQP2 was indistinguishable from AQP2-F204V-
GFP; both were apical upon forskolin stimulation. Although
the effect was subtle in cell (iii), AQP2-F204V-GFP was partly
localized to the apical surface. Generally, the localization of
AQP2-F204V-GFP was clearly more apical when wild-type
AQP2 was also expressed.
To conﬁrm these results biochemically, we transfected the
same cell lines (wild-type AQP2 or vector) with F204V-GFP,
biotinylated surface proteins after forskolin stimulation, and
precipitated the biotinylated proteins (Figure 5D). AQP2-
F204V-GFP is expressed approximately equally in both cell
Figure 5. AQP2-F204V Rescue in Heterozygous Mouse Collecting Ducts
and in Cotransfected MDCK Cells
(A) In heterozygous animals, AQP2 localizes and responds to dDAVP
normally. Immunohistochemistry was carried out on kidney sections
from an Aqp2
F204V/þ mouse, after injection with dDAVP. Kidney sections
were sequentially immunostained for AQP2 (red) and the basolateral
marker AQP3 (green).
(B) Mutant and wild-type AQP2 physically interact. MDCK cells stably
expressing wild-type AQP2 were transiently transfected with GFP tagged
wild-type AQP2, AQP2-F204V, or GFP alone. Solubilized membranes were
immunoprecipitated with a GFP antibody. Total membranes and
immunoprecipitates (GFP-IP) were Western blotted using an antibody
against AQP2 (arrow) or AQP2-GFP fusions (arrowhead).
(C) Wild-type AQP2 rescues the localization defect of mutant AQP2. GFP
fusions of either wild-type AQP2 (WT-GFP, top photomicrographs) or
F204V AQP2 (F204V-GFP, bottom photomicrographs) were expressed in
polarized MDCK stable cell lines expressing vector alone (vector, left
photomicrographs) or AQP2-WT (right photomicrographs). Cells were
stimulated with forskolin, processed for immunocytochemistry, and used
to generate z-sectional images.
(D) Mutant AQP2 is present at the cell surface in cells coexpressing wild-
type AQP2 (AQP2-WT). GFP fused to AQP2-F204V was expressed in
MDCK cells expressing wild-type AQP2 or vector alone. Cells were
stimulated with forskolin, and cell surface biotinylated proteins were
precipitated then analyzed for the presence of wild-type AQP2 (arrow)
and AQP2-F204V (arrowhead) by Western blot.
DOI: 10.1371/journal.pgen.0010020.g005
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Aquaporin-2 Mutant Micelines (Figure 5D, total cells), but is biotinylated only when
wild-type AQP2 is also expressed (Figure 5D, surface
biotinylated). Since only cell surface proteins are accessible
to biotin, these results indicate that AQP2-F204V is trans-
ported to the cell surface when wild-type AQP2 is present,
but not on its own.
Discussion
Aqp2
F204/F204V mice are viable and grow and reproduce
normally. They are, however, severely defective in their ability
to concentrate urine, leading to increased urine output and
water intake, thus making them the ﬁrst mouse model of NDI
to survive to maturity. In humans, NDI is caused by mutations
in Avpr2 or Aqp2. Knockout of the X-linked Avpr2 gene in
mice [15] gave an NDI-like phenotype in male, hemizygous
neonates, but the phenotype could not be assessed in adults as
the mice died within 1 wk of birth. The adult heterozygous
females showed a mild tendency toward increased urinary
output and water intake and decreased urine osmolality.
Knockout of the mouse Aqp2 gene has not been reported. A
knock-in of a human disease-causing mutation (T126M),
however, has been made [18]. These mice have a severe urine-
concentrating defect resulting in dehydration and death
within 1 wk of birth. Curiously, AQP2-T126M does localize
properly in at least a subset of cells. The grossly abnormal
collecting duct morphology makes it impossible to pinpoint
the molecular defect in these knock-in mice.
The T126M knock-in clearly shows that Aqp2 is an essential
gene [18]. The fact that our mice survive shows either that
AQP2-F204V possesses some residual water transporting
ability or that there are AVP-independent pathways for
water reabsorption. Residual activity of AQP2-F204V is likely,
as mutant animals show some small response to dDAVP,
although dDAVP-stimulated urine osmolality remains quite
low. Immunostaining of kidney shows that AQP2-F204V does
not efﬁciently transport water, because it fails to localize to
the apical cell surface after dDAVP treatment. Some residual
activity of AQP2 would imply that some small, undetectable
portion of the mutant protein is getting to the cell surface.
The surface biotinylation experiment (Figure 5D) suggests
that no mutant protein gets to the surface, but this does not
necessarily reﬂect the situation in vivo. While this small
fraction of protein may not be detectable by immunoﬂuo-
rescence, Western blotting shows that some mutant protein
does progress beyond the ER (35–45 kDa species in Figure
3A). Compared to wild-type, mutant protein is enriched in
the high-mannose, core-glycosylated form (31 kDa) and
deﬁcient in nonglycosylated (29 kDa) and complex glycosy-
lated (35–45 kDa) forms. The presence of a reduced but
detectable amount of protein in the 35–45 kDa range
indicates that mutant protein is transported out of the ER,
but with greatly reduced efﬁciency. Colocalization of AQP2-
F204V with the ER protein calnexin in transfected MDCK
cells shows that, while most of the mutant protein is trapped
in the ER, some does progress beyond the ER. Diminished
response to dDAVP, diminished abundance of mature
glycosylated protein in mutant animals, and the transport
of a fraction of mutant protein beyond the ER in MDCK cells
are all consistent with the notion that AQP2-F204V misfold-
ing is limited and that it may retain some residual water
transporting activity. Evidently this residual activity is
sufﬁcient for the viability and growth of mutant animals.
Reduced efﬁciency in exiting the ER may explain why
AQP2-F204V is enriched in the 31 kDa high-mannose
glycosylated form. The high-mannose core oligosaccharide
is added in the ER and is later modiﬁed and elaborated in the
Golgi apparatus [26]. The increase in the high-mannose
glycosylated form of AQP2-F204V may simply reﬂect its
prolonged presence in the ER and exposure to oligosaccharyl
transferase.
While improper localization of AQP2 explains the pheno-
type of homozygous mutant mice, the complete lack of a
phenotype in heterozygous mice is more difﬁcult to explain.
Physiologically, heterozygous mice have no symptoms (see
Figure 1C), and they are indistinguishable from wild type on
immunostaining of kidneys (Figure 5A). The presence of 50%
of the normal amount of wild-type protein may explain the
lack of symptoms, but it cannot explain the lack of any ER-
retained mutant protein. Rather, the phenotype of the
Aqp2
F204V/þ animals suggests that the mutant protein is being
rescued by the wild-type protein. Indeed, de Mattia et al. (26)
have demonstrated that one recessive allele of Aqp2, P262L,
does not properly translocate when expressed by itself in
MDCK cells, but that in the presence of wild-type protein, it
localizes normally. The same mechanism seems to apply in
vivo with Aqp2
F204V/þ mice. In support of this, AQP2-F204V
can interact with wild-type AQP2 (Figure 5B), and when
coexpressed with wild-type protein, AQP2-F204V can reach
the cell surface (Figure 5C bottom right panel and 5D).
Although it has been demonstrated that a recessive allele
(encoding AQP2-R187C) of NDI fails to interact with wild-
type AQP2 [6], here we show that AQP2-F204V does interact
with the wild-type protein, presumably as part of hetero-
tetramers, and represents a rescuable allele, both in vitro and
in vivo.
Immunostaining the kidneys of homozygous Aqp2
F204V/F204V
mice shows that the mutant-expressing collecting duct cells
can not mediate water reabsorption, because it fails to insert
into the apical plasma membrane in response to dDAVP. This
is this ﬁrst in vivo proof of a long-standing hypothesis that
comes from in vitro studies with recessive Aqp2 mutations.
Transfection into MDCK cells of any of several Aqp2
mutations corresponding to recessive human alleles shows
abnormal subcellular localization [25], [27] and failure to
appropriately translocate to the plasma membrane. Thus,
misfolding, retention in the ER, and failure to translocate in
response to dDAVP were proposed as the mechanism for
autosomal recessive NDI. Here we not only prove this
hypothesis but also establish a useful model for human NDI.
This mouse model of NDI based on an Aqp2 allele that can be
rescued provides the opportunity to test therapies, including
gene therapy, that may promote proper subcellular local-
ization.
Materials and Methods
Generation of ENU mice and housing. ENU mutagenized C57BL/6
mice were generated as described [19]. Mice were maintained by
backcrossing affected animals to C57BL/6 and housed in the
Genomics Institute of the Novartis Research Foundation Speciﬁc
Pathogen Free animal facility (La Jolla, California, United States). All
PLoS Genetics | www.plosgenetics.org August 2005 | Volume 1 | Issue 2 | e20 0176
Aquaporin-2 Mutant Miceprocedures were approved by the Genomics Institute of the Novartis
Research Foundation Institutional Animal Care and Use Committee.
Constructs. The complete coding sequence of mouse AQP2
from an IMAGE clone was digested from the pCMV SPORT6
plasmid with EcoRI and NotI and ligated into pcDNA3.1
(Invitrogen, Carlsbad, California, United States). The F204V
mutation was introduced by site-directed mutagenesis (Strata-
gene, La Jolla, California, United States), using the sense
oligonucleotide 59-GATGATCACTGGGTCGTCTGGATCG-
GACCCC-39, and antisense oligonucleotide 59-GGGGTCCGATC-
CAGACGACCCAGTGATCATC-39. To generate GFP fusions of
AQP2, the pCMV SPORT6 AQP2 construct was used in a PCR
reaction with the primers Sp6 and 59-GACTGGATCCCGGCCTT-
GCTGCCGCGCGGCAG-39 to remove the stop codon of AQP2.
The product was digested with KpnI and BamHI and ligated into
pEGFP-N2 (BD Biosciences, San Diego, California, United States).
The F204V mutation was introduced using the same mutagenic
oligonucleotides.
Cell culture and generation of stable cell lines. MDCK cells (CCL-
34; ATCC, Manassas, Virginia, United States) were cultured in DMEM
(Sigma-Aldrich, St. Louis, Missouri, United States) supplemented with
10% FBS (Sigma-Aldrich), 100 U/ml of penicillin, and 100 lg/ml of
streptomycin at 37 8Ci n5 %C O 2. To generate stable MDCK cell lines,
cells were transfected using Lipofectamine 2000 (Invitrogen) and the
pcDNA3.1 expression constructs (containing wild-type AQP2, AQP2-
F204V, or no insert) and selected with 900 lg/ml G418 (Sigma-
Aldrich). Individual colonies were expanded 14 d later. For the
duration of these experiments, the antibiotic was continually added
to the media. Transient GFP transfections were carried out in
subconﬂuent stable cells lines also using Lipofectamine 2000.
Sequencing of Aqp2 and genotyping of mice. All exons of Aqp2 were
ampliﬁed from mouse genomic DNA and sequenced. For genotyping,
exon 4 was ampliﬁed using the primers 59-TCAGAACTTGCCCAC-
TAGCC-39 and 59-TGTAGAGGAGGGAACCGATG-39.
Urine measurements. Total urine output was measured by
separately housing adult mice in Nalgene Metabolic Cages (Mini-
mitter, Bend, Oregon, United States) for 2–3 d and collecting urine
every 24 h period. Urine osmolalities were determined using an
Osmometer (Osmette 5004; Precision Systems, Natick, Massachusetts,
United States). Urine concentrating experiments were carried out by
intraperitoneal injection of dDAVP (0.4 lg/kg). Mice were injected
twice with dDAVP, once at time 0 and again at 30 min. Urine was
collected at the start of the experiment and 30 min after the second
injection.
Kidney membrane preparation. Whole mouse kidneys were
homogenized in 10 mM Tris (pH 7.4), 350 mM sucrose, and 5 mM
EDTA containing protease inhibitors (Sigma-Aldrich, #P-8340) in a
Potter-Elvehjem homogenizer. The homogenate was centrifuged at
2,000 g for 10 min and the supernatant was subjected to ultra-
centrifugation at 100,000 g for 1 h at 4 8C. Pelleted membranes were
resuspended in the same buffer, and protein concentration was
determined by Bradford assay.
Immunoblotting. Kidney membrane fractions (60 lg) were resolved
on a 12% SDS-polyacrylamide gel and transferred to a nitrocellulose
membrane. Membranes were blocked in 5% nonfat milk in Tris-
buffered saline with 0.05% Tween 20 (TBST), followed by an
overnight incubation (at 4 8C) with AQP2 polyclonal antibody (Santa
Cruz Biotechnology, Santa Cruz, California, United States; #sc-9882).
Membranes were washed in TBST then incubated with HRP-
conjugated donkey anti-goat antibody. Membranes were washed
further in TBST and bands were visualized using ECL reagent
(Amersham Biosciences, Little Chalfont, United Kingdom).
Endoglycosidase digestion. Kidney membranes (60 lg) were
incubated in 50 mM sodium phosphate (pH 5.5), 0.1% SDS, and 50
mM b-mercaptoethanol, heated to 100 8C for 5 min, then cooled.
Endoglycosidase H (0.01 units; Sigma-Aldrich) was added and
incubated at 37 8C for 2 h. The reaction was stopped by boiling the
samples in Laemmli buffer. Total reactants were immunoblotted as
described above.
Coimmunoprecipitation and biotinylation in MDCK cells. MDCK
cells stably expressing wild-type AQP2 (grown on 10-cm plates) were
transfected with pEGFP-wild-type AQP2, pEGFP-AQP2-F204V, or
vector alone. The cells were homogenized in 10 mM Tris (pH 7.4), 1
mM EDTA, and 250 mM sucrose 40 h later. The clariﬁed supernatant
was centrifuged at 200,000 g for 30 min. Pelleted membranes were
resuspended in the same buffer but containing 4% sodium
deoxycholate and incubated at 37 8C for 1 h. From the dissolved
membranes, a 30 ll sample was removed and used as the total
membrane fraction. The remaining membranes were diluted with 600
ll of the homogenization buffer, and incubated with 1 ll of GFP
antisera (Invitrogen, #46–0092) and protein A/G sepharose. Following
overnight incubation, the precipitated proteins were washed in RIPA
buffer and ﬁnally boiled in 50 ll of Laemmli buffer. Half of the total
membrane and the IP fractions were processed for immunoblotting.
Cell surface biotinylation was performed in a similar manner.
However, pEGFP-AQP2-F204V, was transfected into MDCK cells
stably expressing wild-type AQP2 and cells made stable with vector
alone. Twenty-four hours post-transfection, cells were stimulated
with forskolin, trypsinized, resuspended in 1 ml of PBS (2.5 3 10
6
cells/ml), and incubated with 0.5 mg of NHS-PEO4-biotin (Pierce
Biotechnology) for 30 min at room temperature. Cells were washed
once in 10 mM Tris (pH 8) and three times in PBS, after which
membranes were puriﬁed and solubilized as described above.
Solubilized membranes were incubated with 20 ll of immobilized
streptavidin (Pierce Biotechnology) for 2 h at 4 8C. Finally the
precipitated proteins were washed in RIPA buffer and boiled in 50 ll
of Laemmli buffer. Total cells and the biotinylated precipitates were
immunoblotting using an antibody to AQP2.
Kidney immunohistochemistry. Whole mouse kidneys were ﬁxed in
10% phosphate-buffered formalin for 24 h. Kidneys were embedded
in parafﬁn, and 5-lm sections were prepared. Following antigen
retrieval using 10 mM sodium citrate (pH 8) for 10 min at 98 8C,
sections were sequentially probed, ﬁrst for AQP3 and then for AQP2.
Sections were incubated in 5% donkey serum and then in goat anti-
AQP3 antibody (1:100; Santa Cruz Biotechnology; #sc-9885). Slides
were washed with PBS and incubated with AlexaFluor 488-conjugated
donkey anti-goat antibody (Molecular Probes, Eugene, Oregon,
United States). The slides were subsequently blocked in 5% chicken
serum, incubated with a rabbit anti-AQP2 antibody (1:250; USB,
Cleveland, Ohio, United States; #A3000–06), which was detected with
a AlexaFluor 594-conjugated chicken anti-rabbit antibody (1:500;
Molecular Probes). The sections were stained with DAPI and mounted
in Vectashield (Vector Labs, Burlingame, California, United States).
Immunocytochemistry on MDCK cells. MDCK stable cell lines
expressing vector alone, wild-type AQP2, or AQP2-F204V (and in
some cases transiently expressing a GFP construct) were grown on
ﬁbronectin-coated coverslips until tight junctions formed. Cells were
treated with or without 150 lM forskolin for 90 min, and ﬁxed in
methanol at  20 8C. Subsequently, cells were washed and permeabi-
lized in 0.2% Triton X-100 for 5 min, and sequentially probed for
AQP2 and organelle markers for either the PM or the ER. AQP2 was
detected using goat anti-AQP2 (1:100; Santa Cruz Biotechnology; #sc-
9882) and a 1:200 dilution of AlexaFluor 488-conjugated donkey anti-
goat secondary antibody. The PM and ER were probed using mouse
anti-Na
þ/K
þ-ATPase (Upstate, Waltham, Massachusetts, United States)
or rabbit anti-calnexin (Stressgen Biotechnology, Victoria, British
Columbia, Canada) antibodies and the secondary antibodies, Cy3-
conjugated goat anti-mouse (1:200; Jackson ImmunoResearch, West
Grove, Pennsylvania, United States) or AlexaFluor 594-conjugated
chicken anti-rabbit (1:200) respectively. Cells were washed in PBS,
counterstained with DAPI, and mounted in Vectashield. In experi-
ments in which GFP fusions were used, AQP2 was probed using the
antibody combination used for kidney immunohistochemistry in
order to detect the AQP2 at 594 nm, to distinguish between the GFP
fusion proteins.
Confocal microscopy. Optical z-section images were collected on a
BioRad (Hercules, California, United States) Rainbow Radiance 2100
Laser Scanning Confocal Microscope. Image stacks were ﬂattened, or
sectioned along the z-axis, then further processed using BioRad Laser
Sharp 2000 software and Image J software (v. 1.32; National Institutes
of Health). Colocalization was performed using the overlay coef-
ﬁcient of Image J software.
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